FDA Inspection
American Reproductive CentersAmerican Reproductive Centers – FDA Inspection, Aug 29, 2012
Record Details
This FDA Inspection record concerns American Reproductive Centers, with an inspection on August 29, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 29, 2012
- Product Type
- Biologics
View Company Profile
ID · 4d95023a-8494-4ef8-b24b-7bf60738f636
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 799852
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.85(c)Reproductive cells or tissues
- 21 CFR 1271.85(a)Infection with communicable disease agents
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Reproductive Centers
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 6, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 12, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 17, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for American Reproductive Centers
- FDA Inspection 1224796 - 2023-12-06
- FDA Inspection 1067661 - 2018-09-12
- FDA Inspection 887867 - 2014-07-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.